192 related articles for article (PubMed ID: 16896943)
21. Calorie restriction increases insulin-stimulated tyrosine phosphorylation of insulin receptor and insulin receptor substrate-1 in rat skeletal muscle.
Dean DJ; Cartee GD
Acta Physiol Scand; 2000 Jun; 169(2):133-9. PubMed ID: 10848643
[TBL] [Abstract][Full Text] [Related]
22. Secretion of atherogenic risk factor apolipoprotein B-100 is increased by a potential mechanism of JNK/PKC-mediated insulin resistance in liver cells.
Jin UH; Kang YJ; Chang YC; Kim CH
J Cell Biochem; 2008 Feb; 103(3):908-19. PubMed ID: 17647275
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes.
Gao Z; Zhang X; Zuberi A; Hwang D; Quon MJ; Lefevre M; Ye J
Mol Endocrinol; 2004 Aug; 18(8):2024-34. PubMed ID: 15143153
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells.
Andreozzi F; Laratta E; Sciacqua A; Perticone F; Sesti G
Circ Res; 2004 May; 94(9):1211-8. PubMed ID: 15044323
[TBL] [Abstract][Full Text] [Related]
25. Serine-threonine kinase 38 is regulated by glycogen synthase kinase-3 and modulates oxidative stress-induced cell death.
Enomoto A; Kido N; Ito M; Takamatsu N; Miyagawa K
Free Radic Biol Med; 2012 Jan; 52(2):507-15. PubMed ID: 22142472
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms by which smoothelin-like protein 1 reverses insulin resistance in myotubules and mice.
Tamas I; Major E; Horvath D; Keller I; Ungvari A; Haystead TA; MacDonald JA; Lontay B
Mol Cell Endocrinol; 2022 Jul; 551():111663. PubMed ID: 35508278
[TBL] [Abstract][Full Text] [Related]
27. The effects of intracellular calcium depletion on insulin signaling in 3T3-L1 adipocytes.
Worrall DS; Olefsky JM
Mol Endocrinol; 2002 Feb; 16(2):378-89. PubMed ID: 11818508
[TBL] [Abstract][Full Text] [Related]
28. Serine phosphorylation proximal to its phosphotyrosine binding domain inhibits insulin receptor substrate 1 function and promotes insulin resistance.
Liu YF; Herschkovitz A; Boura-Halfon S; Ronen D; Paz K; Leroith D; Zick Y
Mol Cell Biol; 2004 Nov; 24(21):9668-81. PubMed ID: 15485932
[TBL] [Abstract][Full Text] [Related]
29. MAP kinases and mTOR mediate insulin-induced phosphorylation of insulin receptor substrate-1 on serine residues 307, 612 and 632.
Gual P; Grémeaux T; Gonzalez T; Le Marchand-Brustel Y; Tanti JF
Diabetologia; 2003 Nov; 46(11):1532-42. PubMed ID: 14579029
[TBL] [Abstract][Full Text] [Related]
30. Increased insulin receptor substrate 1 serine phosphorylation and stress-activated protein kinase/c-Jun N-terminal kinase activation associated with vascular insulin resistance in spontaneously hypertensive rats.
Sugita M; Sugita H; Kaneki M
Hypertension; 2004 Oct; 44(4):484-9. PubMed ID: 15302844
[TBL] [Abstract][Full Text] [Related]
31. Compartmentalization and insulin-induced translocations of insulin receptor substrates, phosphatidylinositol 3-kinase, and protein kinase B in rat liver.
Balbis A; Baquiran G; Bergeron JJ; Posner BI
Endocrinology; 2000 Nov; 141(11):4041-9. PubMed ID: 11089534
[TBL] [Abstract][Full Text] [Related]
32. Insulin resistance in human adipocytes occurs downstream of IRS1 after surgical cell isolation but at the level of phosphorylation of IRS1 in type 2 diabetes.
Danielsson A; Ost A; Lystedt E; Kjolhede P; Gustavsson J; Nystrom FH; Strålfors P
FEBS J; 2005 Jan; 272(1):141-51. PubMed ID: 15634339
[TBL] [Abstract][Full Text] [Related]
33. Phosphorylation of Irs1 at SER-522 inhibits insulin signaling.
Giraud J; Haas M; Feener EP; Copps KD; Dong X; Dunn SL; White MF
Mol Endocrinol; 2007 Sep; 21(9):2294-302. PubMed ID: 17579213
[TBL] [Abstract][Full Text] [Related]
34. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1.
Ozes ON; Akca H; Mayo LD; Gustin JA; Maehama T; Dixon JE; Donner DB
Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4640-5. PubMed ID: 11287630
[TBL] [Abstract][Full Text] [Related]
35. Urotensin II-induced insulin resistance is mediated by NADPH oxidase-derived reactive oxygen species in HepG2 cells.
Li YY; Shi ZM; Yu XY; Feng P; Wang XJ
World J Gastroenterol; 2016 Jul; 22(25):5769-79. PubMed ID: 27433090
[TBL] [Abstract][Full Text] [Related]
36. HC toxin (a HDAC inhibitor) enhances IRS1-Akt signalling and metabolism in mouse myotubes.
Tan HW; Sim AY; Huang SL; Leng Y; Long YC
J Mol Endocrinol; 2015 Dec; 55(3):197-207. PubMed ID: 26373795
[TBL] [Abstract][Full Text] [Related]
37. Effect of hyperglycemia on insulin receptor signaling in the cultured retinal Müller glial cells.
Ola MS
Biochem Biophys Res Commun; 2014 Feb; 444(2):264-9. PubMed ID: 24462861
[TBL] [Abstract][Full Text] [Related]
38. Sequential phosphorylation of insulin receptor substrate-2 by glycogen synthase kinase-3 and c-Jun NH2-terminal kinase plays a role in hepatic insulin signaling.
Sharfi H; Eldar-Finkelman H
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E307-15. PubMed ID: 18029441
[TBL] [Abstract][Full Text] [Related]
39. Short-term in vitro inhibition of glycogen synthase kinase 3 potentiates insulin signaling in type I skeletal muscle of Zucker Diabetic Fatty rats.
Henriksen EJ; Teachey MK
Metabolism; 2007 Jul; 56(7):931-8. PubMed ID: 17570255
[TBL] [Abstract][Full Text] [Related]
40. Modulation of insulin signalling by insulin sensitizers.
Jiang G; Zhang BB
Biochem Soc Trans; 2005 Apr; 33(Pt 2):358-61. PubMed ID: 15787606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
